The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma

Anticancer Research

Volumn 33, Issue 2, 2013, Pages 671-678

  Hsu, Chin Mu ^a,b   Yang, Mei Due ^c,d   Tsai, Chia Wen ^d,e   Ho, Chien Yi ^a,d   Chang, Wen Shin ^d,e   Chang, Sheng Chi ^d,e   Jeng, Long Bin ^d   Tsai, Yuhsin ^a   Tsai, Fuu Jen ^b,d   Bau, Da Tian ^d,e  

^a Graduate Institute of Chinese Medical Science   (Taiwan)

^b Departments of Medical Research   (Taiwan)

^c Department of Clinical Nutrition ^*  (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Caveolin 1; Genotype; Hepatocellular carcinoma; Polymorphism; Real time quantitative reverse transcription; Western blot

Indexed keywords

CAVEOLIN 1; MESSENGER RNA;

ADULT; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CELL INVASION; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CAVEOLIN 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84875892479     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Chen CJ, Yu MW and Liaw YF: Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12: S294-308, 1997.
2. Cancer Registration System Annual Report. Taiwan: Department of Health, Taiwan, 2011.
3. Cohen AW, Hnasko R, Schubert W and Lisanti MP: Role of caveolae and caveolins in health and disease. Physiol Rev 84: 1341-1379, 2004.
4. Glenney JR Jr.: Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem 264: 20163-20166, 1989.
5. Belanger MM, Roussel E and Couet J: Caveolin-1 is downregulated in human lung carcinoma and acts as a candidate tumor suppressor gene. Chest 125: 106S, 2004.
6. Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K, Zhumabayeva B, Siebert PD, Dietel M, Schafer R and Sers C: Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 159: 1635-1643, 2001.
7. Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM and Schneider U: Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 158: 833-839, 2001.
8. Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T, Okushiba S, Kondo S and Katoh H: Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94: 929-933, 2002.
9. Yang G, Truong LD, Wheeler TM and Thompson TC: Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker. Cancer Res 59: 5719-5723, 1999.
10. Tsou YA, Tsai CW, Tsai MH, Chang WS, Li FJ, Liu YF, Chiu CF, Lin CC and Bau DT: Association of caveolin-1 genotypes with nasopharyngeal carcinoma susceptibility in Taiwan. Anticancer Res 31: 3629-3632, 2011.
11. Chen HL, Fan LF, Gao J, Ouyang JP and Zhang YX: Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma. Oncol Rep 25: 359-366, 2010.
12. Haeusler J, Hoegel J, Bachmann N, Herkommer K, Paiss T, Vogel W and Maier C: Association of a CAV-1 haplotype to familial aggressive prostate cancer. Prostate 65: 171-177, 2005.
13. Langeberg WJ, Tahir SA, Feng Z, Kwon EM, Ostrander EA, Thompson TC and Stanford JL: Association of caveolin-1 and-2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes. Prostate 70: 1020-1035, 2010.
14. Wu HC, Chang CH, Tsou YA, Tsai CW, Lin CC and Bau DT: Significant association of caveolin-1 (CAV1) genotypes with prostate cancer susceptibility in Taiwan. Anticancer Res 31: 745-749, 2011.
15. Li T, Sotgia F, Vuolo MA, Li M, Yang WC, Pestell RG, Sparano JA and Lisanti MP: Caveolin-1 mutations in human breast cancer: Functional association with estrogen receptor alphapositive status. Am J Pathol 168: 1998-2013, 2006.
16. Liu LC, Su CH, Wang HC, Tsai CW, Chang WS, Ho CY, Wu CI, Li FJ, Lin CH, Lane HY and Bau DT: Significant association of caveolin-1 (CAV1) genotypes with breast cancer in Taiwan. Anticancer Res 31: 3511-3515, 2011.
17. Bau DT, Tsai MH, Tsou YA, Wang CH, Tsai CW, Sun SS, Hua CH, Shyue SK and Tsai RY: The association of caveolin-1 genotypes with oral cancer susceptibility in Taiwan. Ann Surg Oncol 18: 1431-1438, 2011.
18. Yang MD, Tsai RY, Liu CS, Chang CH, Wang HC, Tsou YA, Wang CH, Lin CC, Shyue SK and Bau DT: Association of caveolin-1 polymorphisms with colorectal cancer susceptibility in Taiwan. World J Gastrointest Oncol 2: 326-331, 2010.
19. Bau DT, Chang CH, Tsai RY, Wang HC, Wang RF, Tsai CW, Yao CH, Chen YS, Shyue SK and Huang CY: Significant association of caveolin-1 genotypes with bladder cancer susceptibility in Taiwan. Chin J Physiol 54: 153-160, 2011.
20. Koleske AJ, Baltimore D and Lisanti MP: Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 92: 1381-1385, 1995.
21. Wang S, Jia L, Zhou H, Wang X and Zhang J: Caveolin-1 promotes the transformation and anti-apoptotic ability of mouse hepatoma cells. IUBMB Life 60: 693-699, 2008.
22. Wang S, Jia L, Zhou H, Shi W and Zhang J: Knockdown of caveolin-1 by siRNA inhibits the transformation of mouse hepatoma H22 cells in vitro and in vivo. Oligonucleotides 19: 81-88, 2009.
23. Su CH, Liu LC, Hsieh YH, Wang HC, Tsai CW, Chang WS, Ho CY, Wu CI, Lin CH, Lane HY and Bau DT: Association of alpha B-crystallin (CRYAB) genotypes with breast cancer susceptibility in Taiwan. Cancer Genomics Proteomics 8: 251-254, 2011.
24. Yang MD, Hsu YM, Kuo YS, Chen HS, Chang CL, Wu CN, Chang CH, Liao YM, Wang HC, Wang MF and Bau DT: Significant association of Ku80 single nucleotide polymorphisms with colorectal cancer susceptibility in Central Taiwan. Anticancer Res 29: 2239-2242, 2009.
25. Chang CH, Chang CL, Tsai CW, Wu HC, Chiu CF, Wang RF, Liu CS, Lin CC and Bau DT: Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. Anticancer Res 29: 1777-1782, 2009.
26. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG and Lisanti MP: Targeted down-regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17: 6633-6648, 1998.
27. Bender FC, Reymond MA, Bron C and Quest AF: Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 60: 5870-5878, 2000.
28. Razani B, Schlegel A, Liu J and Lisanti MP: Caveolin-1, a putative tumour suppressor gene. Biochem Soc Trans 29: 494-499, 2001.
29. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG and Lisanti MP: Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of CAV-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279: 51630-51646, 2004.
30. Fiucci G, Ravid D, Reich R and Liscovitch M: Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21: 2365-2375, 2002.
31. Lee SW, Reimer CL, Oh P, Campbell DB and Schnitzer JE: Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16: 1391-1397, 1998.
32. Pflug BR, Reiter RE and Nelson JB: Caveolin expression is decreased following androgen deprivation in human prostate cancer cell lines. Prostate 40: 269-273, 1999.
33. Thompson TC: Metastasis-related genes in prostate cancer: The role of caveolin-1. Cancer Metastasis Rev 17: 439-442, 1998.
34. Rajjayabun PH, Garg S, Durkan GC, Charlton R, Robinson MC and Mellon JK: Caveolin-1 expression is associated with highgrade bladder cancer. Urology 58: 811-814, 2001.
35. Jia L, Wang S, Zhou H, Cao J, Hu Y and Zhang J: Caveolin-1 up-regulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines. Int J Biochem Cell Biol 38: 1584-1593, 2006.
36. Wang S, Yu S, Shi W, Ge L, Yu X, Fan J and Zhang J: Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling. IUBMB Life 63: 775-782, 2011.
37. Moore J, McKnight AJ, Simmonds MJ, Courtney AE, Hanvesakul R, Brand OJ, Briggs D, Ball S, Cockwell P, Patterson CC, Maxwell AP, Gough SC and Borrows R: Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure. JAMA 303: 1282-1287, 2010.